sk&f 97541 has been researched along with Alzheimer Disease in 1 studies
3-aminopropyl(methyl)phosphinic acid: structure given in first source; GABA-A receptor antagonist
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dissel, S | 1 |
| Angadi, V | 1 |
| Kirszenblat, L | 1 |
| Suzuki, Y | 1 |
| Donlea, J | 1 |
| Klose, M | 1 |
| Koch, Z | 1 |
| English, D | 1 |
| Winsky-Sommerer, R | 1 |
| van Swinderen, B | 1 |
| Shaw, PJ | 1 |
1 other study available for sk&f 97541 and Alzheimer Disease
| Article | Year |
|---|---|
Sleep restores behavioral plasticity to Drosophila mutants.
Topics: Adenylyl Cyclases; Alzheimer Disease; Animals; Animals, Genetically Modified; Behavior, Animal; Dise | 2015 |